*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*please excuse the google/sponsors ad , it helps us to cover website operational cost.
Publish News, Views, Consciences, Etc.
No SignUp, just
With Our Open Profile: WerMCBzen
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Antibody Drug Conjugates Market (5th Edition), 2019-2030.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of payload
Type of linker
Target Indications
Target Antigen
Technology Providers
Key Geographies
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
Key companies covered in the report
Request for PDF Sample of this Report:
https://www.rootsanalysis.com/reports/270/request-sample.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
Also Visit Our Latest Publication
In Silico / Computer-Aided Drug Discovery Services Market
Antibody Contract Manufacturing Market
Biopharma Contract Manufacturing MarketCell Therapy Manufacturing Market
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.
To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html
The over USD 5 billion (by 2030) financial opportunity within the endocannabinoid system targeted therapeutics market has been analyzed across the following segments:
Asia-Pacific and the Rest of the World
The “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:
Table of Contents
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. MARKET LANDSCAPE: ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS
5. COMPANY PROFILES
6. ACADEMIC GRANTS ANALYSIS
7. PARTNERSHIPS AND COLLABORATIONS
8. MERGERS AND ACQUISITIONS
9. DRUG DEVELOPMENT STRATEGY ANALYSIS
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11. CONCLUDING REMARKS
12. EXECUTIVE INSIGHTS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
Roots Analysis has done a detailed study on Endocannabinoid System Targeted Therapeutics Market, 2020-2030“ covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html
Key Market Insights
For more information, please visit “Endocannabinoid System Targeted Therapeutics Market, 2020-2030.“
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Neuropharmacology and Working Mechanism of the Endocannabinoid System
3.3. Potential Therapeutic Applications of Cannabinoids
3.4. Legal Aspects and Regulations
3.5. Existing Challenges
3.6. Future of Cannabinoid Therapies
4. MARKET LANDSCAPE: ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS
4.1. Chapter Overview
4.2. Drugs Targeting Endocannabinoid System: Marketed and Development Pipeline
4.2.1. Analysis by Phase of Development
4.2.2. Analysis by Target Therapeutic Area
4.2.3. Analysis by Route of Administration
4.2.4. Analysis by Dosing Frequency
4.2.5. Analysis by Target Receptor
4.2.6. Grid Analysis: Distribution by Phase of Development, Target Therapeutic Area and Target Receptor
4.3. Endocannabinoid System Targeted Therapeutics: List of Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size and Geographical Location
4.4. List of Cannabis Suppliers
5. COMPANY PROFILES
5.1. Chapter Overview
5.2. GW Pharmaceuticals
5.2.1. Company Overview
5.2.2. Financial Information
5.2.3. Endocannabinoid Targeting Therapeutics Portfolio
5.2.4. Recent Developments and Future Outlook
5.3. Corbus Pharmaceuticals
5.3.1. Company Overview
5.3.2. Endocannabinoid Targeting Therapeutics Portfolio
5.3.3. Recent Developments and Future Outlook
5.4. Tilray
5.4.1. Company Overview
5.4.2. Financial Information
5.4.3. Endocannabinoid Targeting Therapeutics Portfolio
5.4.3.2. Recent Developments and Future Outlook
5.5. Pure Green
5.5.1. Company Overview
5.5.2. Endocannabinoid Targeting Therapeutics Portfolio
5.6. Tetra Bio-Pharma
5.6.1. Company Overview
5.6.2. Endocannabinoid Targeting Therapeutics Portfolio
5.6.3. Recent Developments and Future Outlook
5.7. Botanix Pharmaceuticals
5.7.1. Company Overview
5.7.2. Endocannabinoid Targeting Therapeutics Portfolio
5.7.3. Recent Developments and Future Outlook
5.8. Kalytera Therapeutics
5.8.1. Company Overview
5.8.2. Endocannabinoid Targeting Therapeutics Portfolio
5.8.3. Recent Developments and Future Outlook
5.9. Therapix Biosciences
5.9.1. Company Overview
5.9.2. Endocannabinoid Targeting Therapeutics Portfolio
5.9.3. Recent Developments and Future Outlook
5.10. Zelira Therapeutics
5.10.1. Company Overview
5.10.2. Endocannabinoid Targeting Therapeutics Portfolio
5.10.3. Recent Developments and Future Outlook
5.11. Avicanna
5.11.1. Company Overview
5.11.2. Financial Information
5.11.3. Endocannabinoid Targeting Therapeutics Portfolio
5.11.4. Recent Developments and Future Outlook
5.12. GB Sciences
5.12.1. Company Overview
5.12.2. Financial Information
5.12.3. Endocannabinoid Targeting Therapeutics Portfolio
5.12.4. Recent Developments and Future Outlook
6. ACADEMIC GRANTS ANALYSIS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Endocannabinoid System Targeted Therapeutics: List of Grants Awarded by National Institutes of Health (NIH)
6.3.1. Analysis by Year of Grant Award
6.3.2. Analysis by Amount Awarded
6.3.3. Analysis by Administering Institute Center
6.3.4. Analysis by Funding Institute Center
6.3.5. Analysis by Support Period
6.3.6. Analysis by Funding Institute Center and Support Period
6.3.7. Analysis by Type of Grant Application
6.3.8. Analysis by Purpose of Grant Award
6.3.9. Analysis by Grant Mechanism
6.3.10. Word Cloud Analysis: Emerging Focus Areas
6.3.11. Analysis by Study Section Involved
6.3.12. Popular NIH Departments: Analysis by Number of Grants
6.3.13. Analysis by Types of Recipient Organizations
6.3.14. Prominent Program Officers: Analysis by Number of Grants
6.3.15. Popular Recipient Organizations: Analysis by Number of Grants
6.3.16. Regional Analysis of Recipient Organizations
7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models
7.3. Endocannabinoid Targeted Therapeutics: List of Partnerships and Collaborations
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.3. Analysis by Type of Partnership and Target Disease Indication
7.3.4. Analysis by Year of Partnership and Type of Partner
7.3.5. Most Active Players: Analysis by Number of Partnerships
7.3.6. Regional Analysis
7.3.7. Intercontinental and Intracontinental Agreements
8. MERGERS AND ACQUISITIONS
8.1. Chapter Overview
8.2. Acquisition Models
8.3. Endocannabinoid Targeted Therapeutics: Mergers and Acquisitions
8.3.1. Cumulative Year-wise Trend
8.3.2. Analysis by Type of Acquisition
8.3.3. Year of Acquisitions and Deal Financials
8.3.4. Geographical Analysis of Mergers and Acquisitions
8.3.5. Ownership Change Matrix
8.3.6. Most Active Players: Analysis by Number of Acquisitions
8.3.7. Key Value Drivers
8.3.8. Valuation Analysis: Acquisition Deal Multiples
9. DRUG DEVELOPMENT STRATEGY ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Strategies Adopted by Late-Stage Drug Candidate Developers
10. MARKET FORECAST AND OPPORTUNITY ANALYSIS
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Endocannabinoid Targeted Therapeutics Market, 2020-2030
10.4. Global Endocannabinoid Targeted Therapeutics Market: Individual Product Sales Forecasts
10.4.1. EPIDIOLEX® (GW Pharmaceuticals)
10.4.1.1. Target Patient Population
10.4.1.2. Sales Forecast
10.4.2. Sativex® (GW Pharmaceuticals)
10.4.2.1. Target Patient Population
10.4.2.2. Sales Forecast
10.4.3. PPP011 (Caumz)
10.4.3.1. Target Patient Population
10.4.3.2. Sales Forecast
10.4.4. Lenabasum
10.4.4.1. Target Patient Population
10.4.4.2. Sales Forecast
10.4.5. CannEpil™
10.4.5.1. Target Patient Population
10.4.5.2. Sales Forecast
10.5. Global Endocannabinoid System Targeted Therapeutics Market: Focus on CB1, CB2 and TRPV1 Receptors
10.6. Global Endocannabinoid System Targeted Therapeutics Market: Distribution by Region, 2020-2030
10.6.1. Endocannabinoid System Targeted Therapeutics Market in North America, 2020-2030
10.6.2. Endocannabinoid System Targeted Therapeutics Market in Europe, 2020-2030
10.6.3. Endocannabinoid System Targeted Therapeutics Market in Asia-Pacific, 2020-2030
10.6.4. Endocannabinoid System Targeted Therapeutics Market in Rest of the World, 2020-2030
10.7. Global Endocannabinoid System Targeted Therapeutics Market: Distribution by Target Therapeutic Area, 2020-2030
10.7.1. Global Endocannabinoid System Targeted Therapeutics Market for Autoimmune Diseases, 2020-2030
10.7.2. Global Endocannabinoid System Targeted Therapeutics Market for Genetic Disorders, 2020-2030
10.7.3. Global Endocannabinoid System Targeted Therapeutics Market for Neurological Disorders, 2020-2030
10.7.4. Global Endocannabinoid System Targeted Therapeutics Market for Pain Disorders, 2020-2030
10.8. Global Endocannabinoid System Targeted Therapeutics Market: Distribution by Route of Administration
10.8.1. Global Endocannabinoid System Targeted Therapeutics Market for Oral Therapies, 2020-2030
10.8.5. Global Endocannabinoid System Targeted Therapeutics Market for Inhalation Therapies, 2020-2030
11. CONCLUDING REMARKS
12. EXECUTIVE INSIGHTS
12.1. Chapter Overview
12.2 Zelira Therapeutics US
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Oludare Odumosu, Chief Executive Officer
12.3. GB Sciences
12.3.1. Company Snapshot
12.3.2. Interview Transcript: Andrea Small-Howard, Chief Scientific Officer
12.4. Tetra Bio-Pharma
12.4.1. Company Snapshot
12.4.2. Interview Transcript: Steeve Néron, Chief Operating Officer
12.5 Vireo Health
12.5.1. Company Snapshot
12.5.2. Interview Transcript: Stephen Dahmer, Chief Medical Officer
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions
Roots Analysis is pleased to announce the publication of its recent study, titled, “Endocannabinoid System Targeted Therapeutics Market, 2020-2030.“
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of endocannabinoid system targeting drugs, over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
Key companies covered in the report
For more information please click on the following link:
Other Recent Offerings
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
London
Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to its list of offerings.
Over time, extensive R&D on the potential health benefits of cannabis, have enabled medical researchers to identify a number of pharmacologically active ingredients that offer clinical benefit, minus the addictive properties of the crude substance. Currently, several stakeholders in the pharmaceutical industry are actively engaged in the efforts to develop leads based on natural and synthetic derivatives of cannabinoids.
To order this 250+ page report, which features 140+ figures and 170+ tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html
Key Market Insights
Over 175 drugs targeting the endocannabinoid system are currently under development
Most cannabinoid-based drug candidates are being developed to target the CB1 and CB2 receptors. Nearly 45% of such drugs are presently being investigated in clinical trials, while 50% are in the preclinical / discovery phase. Majority of these therapies (60%) are designed for oral administration.
More than 60 companies claim to develop endocannabinoid system targeted therapeutics
Post 2010, there has been a significant rise in the number of companies working in this domain; such companies represent 63% of the total number of players. Majority of the firms engaged in this domain (74%) are based in North America, followed by those headquartered in Asia-Pacific (16%), Europe (8%) and Latin America (2%).
Partnership activity has grown at an annualized rate of 35%, between 2017 and 2019
The maximum number of partnerships were observed in 2019 within this segment of the pharmaceutical industry. Majority of these agreements were reported to have been inked for research purposes (20%). In addition, more than 35 merger / acquisition deal were signed between 2016 and 2020; service / facility expansion emerged as the most prominent key value drivers for such agreements.
Close to 600 grants were awarded for supporting research on endocannabinoid system targeted therapeutics, since 2016
Almost 45% of the total amount awarded in the form of grants, was under the R01 (in support of health-related research and development based on the mission of the NIH) mechanism. Further, grants (394) worth USD 147 million were awarded to research projects related to endocannabinoid system.
At present, therapies intended for the treatment of neurological disorders represent the majority share of the overall endocannabinoid system targeted therapeutics market
Most of the therapies targeting neurological disorders are intended for the treatment of epilepsy. In addition to neurological disorders, therapies intended for autoimmune disorders, cancer and genetic disorders are likely to capture significant market opportunity in the foreseen future.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/316/request-sample.html
Key Questions Answered
The over USD 5 billion (by 2030) financial opportunity within the endocannabinoid system targeted therapeutics market has been analyzed across the following segments:
The report features inputs from eminent industry stakeholders, according to whom, endocannabinoid system targeted therapeutics are considered as a promising alternative for the treatment of a diverse array of symptoms associated with a myriad of human diseases. The report includes detailed transcripts of the discussions held with industry experts.
The research includes detailed profiles of key players (listed below); each profile features an overview of the company, its financial information (if available), drug portfolio, recent developments and an informed future outlook.
For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html or email sales@rootsanalysis.com
You may also be interested in the following titles:
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
To order this 180+ page report, please visit this AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030
Key Inclusions:
The USD 3.04 billion (by 2030) financial opportunity within the AR / VR based healthcare digital marketing service providers market has been analyzed across the following segments:
To request sample pages, please visit this link
Key Questions Answered
You may also be interested in the following titles:
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers in the foreseen future. Owing to the rising interest of big pharma players in this domain, we expect an escalated industry-wide adoption of such technologies.
To order this 180+ page report, which features 45+ figures and 70+ tables, please visit AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030
The USD 3.04 billion (by 2030) financial opportunity within the AR / VR based healthcare digital marketing service providers market has been analyzed across the following segments:
Key companies covered in the report
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. AR / VR Based Healthcare Digital Marketing Companies: Current Market Landscape
5. Company Competitiveness Analysis
6. Company Profiles
7. Potential Strategic Partners
8. Digital Marketing Related Initiatives of Big
Pharma Players
9. Case Study
10. Market Forecast
11. Executive Insights
12. Conclusion
13. Appendix 1: Tabulated Data
14. Appendix 2: List of Companies and Organisations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
To order this 180+ page report, which features 45+ figures and 70+ tables, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html
Key Market Insights
For more information, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Key Challenges in Pharmaceutical Marketing
3.2.1. Need for Product Differentiation
3.2.2. Growing Demand for Patient Centric Healthcare
3.2.3. Lack of Standard Performance Metrics
3.2.4. Need for Scientific Communication
3.3. Importance of Digital Marketing
3.4. Popular Digital Marketing Strategies
3.4.1. Social Media Marketing
3.4.2. Content Marketing Strategy
3.4.3. Marketing Automation
3.4.4. Search Engine Optimization and Marketing
3.4.5. Artificial Intelligence based Marketing
3.5. Use of Augmented Reality and Virtual Reality (AR / VR) in
Pharmaceutical Digital Marketing
3.6. Growth Constraints in AR / VR Industry
3.7. Future Perspectives
4. AR / VR BASED HEALTHCARE DIGITAL MARKETING COMPANIES: CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Digital Marketing in Pharmaceutical Industry: Overall Market Landscape
4.2.1. Analysis by Type of Technology
4.2.2. Analysis by AR / VR based Services Offered
4.2.3. Analysis by Type of Digital Marketing Services Offered
4.2.4. Analysis by Secondary Marketing Services Offered
4.2.5. Analysis by Year of Establishment
4.2.6. Analysis by Company Size
4.2.7. Analysis by Geographical Location
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.2.1. Competitiveness Analysis: AR / VR based Digital Marketing
Service Providers based in North America
5.2.2. Competitiveness Analysis: AR / VR based Digital Marketing
Service Providers based in Europe
5.2.3. Competitiveness Analysis: AR / VR based Digital Marketing
Service Providers based in Asia-Pacific
6. COMPANY PROFILES
6.1. Chapter Overview
6.2. ARworks
6.2.1. Company Overview
6.2.2. Recent Developments and Future Outlook
6.3. CG Life
6.3.1. Company Overview
6.3.2. Recent Developments and Future Outlook
6.4. CubeZoo
6.4.1. Company Overview
6.4.2. Recent Developments and Future Outlook
6. 5. Impact XM
6. 5.1. Company Overview
6. 5.2. Recent Developments and Future Outlook
6.6. INVIVO Communications
6.6.1. Company overview
6.6.2. Recent Developments and Future Outlook
6.7. Mindgrub
6.7.1. Company Overview
6.7.2. Recent Developments and Future Outlook
6.8. Mirum
6.8.1. Company Overview
6.8.2. Recent Developments and Future Outlook
6.9. PIXACORE
6.9.1. Company Overview
6.9.2. Recent Developments and Future Outlook
6.10. Quast Media
6.10.1. Company Overview
6.10.2. Recent Developments and Future Outlook
6.11. Random42
6.11.1. Company Overview
6.11.2. Recent Developments and Future Outlook
6.12. Tipping Point Media
6.12.1. Company Overview
6.12.2. Recent Developments and Future Outlook
6.13. vStream
6.13.1. Company Overview
6.13.2. Recent Developments and Future Outlook
7. POTENTIAL STRATEGIC PARTNERS
7.1. Chapter Overview
7.2. Scope and Methodology
7.3. Potential Strategic Partners for Digital Marketing Companies
7.3.1. Most Likely Partners
7.3.2. Likely Partners
7.3.3. Less Likely Partners
7.3.4. Least Likely Partners
8. DIGITAL MARKETING RELATED INITIATIVES OF BIG
PHARMA PLAYERS
8.1. Chapter Overview
8.1.1. Analysis by Year
8.1.2. Analysis by Type of Initiative
8.1.3. Analysis by Type of Application Area
8.1.4. Analysis by Type of Solution
8.1.5. Leading Players: Analysis by Number of Initiatives
8.1.6. Leading Partners: Analysis by Number of Initiatives
9. CASE STUDY
9.1. Chapter Overview
9.2. Narola Infotech for Zocular
9.2.1. Narola Infotech
9.2.2. Zocular
9.2.3. Business Needs
9.2.4. Objectives Achieved and Solutions Provided
9.3. Viscira for Actelion
9.3.1. Viscira
9.3.2. Actelion
9.3.3. Business Needs
9.3.4. Objectives Achieved and Solutions Provided
9.4. SoftCover VR for LifeLabs
9.4.1. SoftCover VR
9.4.2. LifeLabs
9.4.3. Business Needs
9.4.4. Objectives Achieved and Solutions Provided
9.5. Virtual Reality Ireland for MISA
9.5.1. Virtual Reality Ireland
9.5.2. MISA
9.5.3. Business Needs
9.5.4. Objectives Achieved and Solutions Provided
9.6. ViitorCloud for vCura
9.6.1. ViitorCloud
9.6.2. vCura
9.6.3. Business Needs
9.6.4. Objectives Achieved and Solutions Provided
9.7. Kwebmaker for Lilavati Hospital
9.7.1. Kwebmaker
9.7.2. Lilavati Hospital
9.7.3. Business Needs
9.7.4. Objectives Achieved and Solutions Provided
9.8. Intermind for My Health Meter
9.8.1. Intermind
9.8.2. My Health Meter
9.8.3. Business Needs
9.8.4. Objectives Achieved and Solutions Provided
9.9. VR Vision for Providence Healthcare
9.9.1. VR Vision
9.9.2. Providence Healthcare
9.9.3. Business Needs
9.9.4. Objectives Achieved and Solutions Provided
9.10. CitrusBits for Zoetis
9.10.1. CitrusBits
9.10.2. Zoetis
9.10.3. Business Needs
9.10.4. Objectives Achieved and Solutions Provided
10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Overall AR / VR based Digital Marketing Opportunity in Healthcare
Industry, 2020-2030
10.4. AR / VR based Digital Marketing Opportunity in Healthcare Industry:
Distribution by Type of Technology, 2020 and 2030
10.5. AR / VR based Digital Marketing Opportunity in Healthcare Industry:
Distribution by Product, 2020 and 2030
10.6. AR / VR based Digital Marketing Opportunity in Healthcare Industry:
Distribution by End-User, 2020 and 2030
10.7. AR / VR based Digital Marketing Opportunity in Healthcare Industry:
Distribution by Key Geographical Regions, 2020 and 2030
10.7.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America, 2020-2030
10.7.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America: Distribution by Type of Technology, 2020 and 2030
10.7.1.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America: Share of AR based Services, 2020-2030
10.7.1.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America: Share of VR based Services, 2020-2030
10.7.1.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America: Share of Mixed Reality (MR) based Services, 2020-
2030
10.7.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America: Distribution by Type of Product, 2020 and 2030
10.7.1.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America: Share of Hardware Products, 2020-2030
10.7.1.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in North America: Share of Software Products, 2020-2030
10.7.2. AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe, 2020-2030
10.7.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe: Distribution by Type of Technology, 2020 and 2030
10.7.2.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe: Share of AR based Services, 2020-2030
10.7.2.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe: Share of VR based Services, 2020-2030
10.7.2.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe: Share of MR based Services, 2020-2030
10.7.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe: Distribution by Type of Product, 2020 and 2030
10.7.2.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe: Share of Hardware Products, 2020-2030
10.7.2.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Europe: Share of Software Products, 2020-2030
10.7.3. AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific, 2020-2030
10.7.3.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific: Distribution by Type of Technology, 2020 and 2030
10.7.3.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific: Share of AR based Services, 2020-2030
10.7.3.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific: Share of VR based Services, 2020-2030
10.7.3.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific: Share of MR based Services, 2020-2030
10.7.3.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific: Distribution by Type of Product, 2020 and 2030
10.7.3.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific: Share of Hardware Products, 2020-2030
10.7.3.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Asia-Pacific: Share of Software Products, 2020-2030
10.7.1. AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World, 2020-2030
10.7.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World: Distribution by Type of Technology, 2020 and
2030
10.7.1.1.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World: Share of AR based Services, 2020-2030
10.7.1.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World: Share of VR based Services, 2020-2030
10.7.1.1.3.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World: Share of MR based Services, 2020-2030
10.7.1.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World: Distribution by Type of Product, 2020 and 2030
10.7.1.2.1.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World: Share of Hardware Products, 2020-2030
10.7.1.2.2.AR / VR based Digital Marketing Opportunity in Healthcare Industry
in Rest of the World: Share of Software Products, 2020-2030
11. EXECUTIVE INSIGHTS
11.1. Chapter Overview
11.2. Unanimity Information & Technology
11.2.1. Interview Transcript: Pritam Sahu, Director, Unanimity Information &
Technology
11.3. Kwebmaker
11.3.1. Interview Transcript: Dhananjay Arora, Founder and CEO,
Kwebmaker
12. CONCLUSION
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANISATIONS
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content
Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
The report features an extensive study of the current market landscape and future opportunities associated with the AR / VR based digital marketing industry in the healthcare domain. Amongst other elements, the report features:
Key companies covered in the report
For more information, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html
Other recent offerings
You may also be interested in the following titles:
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415 gaurav.chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies
Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings.
Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers in the foreseen future. Owing to the rising interest of big pharma players in this domain, we expect an escalated industry-wide adoption of such technologies.
To order this 180+ page report, which features 45+ figures and 70+ tables, please visit https://www.rootsanalysis.com/reports/view_document/healthcare-digital-marketing/323.html
Key Market Insights
More than 125 companies claim to offer different AR / VR based digital marketing services to the healthcare and pharma industry.
The majority of players engaged in providing AR / VR based digital marketing services to the healthcare and pharmaceutical industry are small-sized companies (63%), followed by mid-sized (32%) and large players (5%). In addition, majority (38%) of the players were established during the period 2011-2015.
Several big pharma players have taken significant strides in in the field of AR / VR
These instances are either by collaborating with digital marketing service providers or through development of in-house capabilities. Majority (18%) of the instances were recorded in the year 2018.
More than 350 industry players have been identified as likely partners for AR / VR based digital marketing service providers
The potential strategic partners have been identified by evaluating more than 4,500 industry sponsored clinical trials (including phase I / II, phase II and phase II / III trials), and have been analyzed based on our proprietary scoring criteria.
Currently, a significant proportion (57%) of service revenues is generated from AR based digital marketing projects
In 2020, VR based projects are anticipated to contribute to 42% of the overall market share. It is worth mentioning that, in the foreseen future, service revenues generated through MR based technologies are anticipated to grow at a CAGR of 5% till 2030.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/323/request-sample.html
Key Questions Answered
The USD 3.04 billion (by 2030) financial opportunity within the AR / VR based healthcare digital marketing service providers market has been analyzed across the following segments:
The report features inputs from eminent industry stakeholders, according to whom, a significant increase in adoption of AR / VR based digital marketing services is anticipated in pharmaceutical industry, in the foreseen future. The report includes detailed transcripts of the discussions held with the following experts:
The research includes detailed profiles of key players engaged in this domain; each profile features an overview of the company, recent developments and an informed future outlook.
For additional details, please visit
You may also be interested in the following titles:
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.Chaudhary@rootsanalysis.com
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
: ) Play with MCB Posts
as if those are your posts !
Power to Edit/Add/Improve any Post !
Visit MCB Policy
MCB Post
MCB Page:
*RELATED Video(s) to your this interest, Tap the Image to Retrieve the Video. Some times you won't see any related video(s) for youtube API & Quota issue, or some times you see video(s) unrelated. please excuse the drawback while such stuff happens.
No Video(s) Found,*this search pane is awesome, also enhanced by google, you won't h'v to leave MCB for your regular google search, thanks to magical power of ajax & jquery.
*please keep in mind your post/page is always editable by the open online profile: WerMCBzen.
MCB is an Open Online Platform with a unique, one & only Open Online Profile – ‘WerMCBzen(wermcbzen)’ where you Possess the Power to Edit/Add/Improve any post or anybody’s content, but you should keep in mind, that Power always comes with some sort of responsibilities. So please be responsible by yourself to your Power. It is made with Love for Lovable & Sensible People Only.
Edit: You're Empowered for Excellence !
